SG49078A1 - Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade - Google Patents

Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Info

Publication number
SG49078A1
SG49078A1 SG1996005829A SG1996005829A SG49078A1 SG 49078 A1 SG49078 A1 SG 49078A1 SG 1996005829 A SG1996005829 A SG 1996005829A SG 1996005829 A SG1996005829 A SG 1996005829A SG 49078 A1 SG49078 A1 SG 49078A1
Authority
SG
Singapore
Prior art keywords
ropivacaine
manufacture
pharmaceutical
pct
minimal motor
Prior art date
Application number
SG1996005829A
Other languages
English (en)
Inventor
Eek Arne Torsten
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20390432&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG49078(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of SG49078A1 publication Critical patent/SG49078A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Insulation, Fastening Of Motor, Generator Windings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Electromechanical Clocks (AREA)
  • Air Conditioning Control Device (AREA)
  • Particle Accelerators (AREA)
SG1996005829A 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade SG49078A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939302218A SE9302218D0 (sv) 1993-06-28 1993-06-28 New use

Publications (1)

Publication Number Publication Date
SG49078A1 true SG49078A1 (en) 1998-05-18

Family

ID=20390432

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996005829A SG49078A1 (en) 1993-06-28 1994-05-26 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade

Country Status (33)

Country Link
US (2) US5670524A (et)
EP (1) EP0706395B1 (et)
JP (1) JP3725541B2 (et)
CN (1) CN1074918C (et)
AT (1) ATE216237T1 (et)
BR (1) BR9406865A (et)
CA (1) CA2165446C (et)
CZ (1) CZ283300B6 (et)
DE (2) DE706395T1 (et)
DK (1) DK0706395T3 (et)
EE (1) EE03205B1 (et)
ES (1) ES2099048T3 (et)
FI (1) FI956269A0 (et)
GR (1) GR970300013T1 (et)
HK (1) HK1010344A1 (et)
HU (1) HU218949B (et)
IL (1) IL110006A (et)
IS (1) IS4174A (et)
LT (1) LT3449B (et)
LV (1) LV12918B (et)
MY (1) MY119360A (et)
NO (1) NO955313L (et)
NZ (1) NZ268110A (et)
PH (1) PH31258A (et)
PL (1) PL175518B1 (et)
PT (1) PT706395E (et)
RU (1) RU2152215C1 (et)
SA (1) SA94150010B1 (et)
SE (1) SE9302218D0 (et)
SG (1) SG49078A1 (et)
SK (1) SK280111B6 (et)
TW (1) TW285640B (et)
WO (1) WO1995000148A1 (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use
EP0998286A2 (en) * 1997-07-21 2000-05-10 Darwin Discovery Limited Use of levobupivacaine
US20060270708A1 (en) * 2005-05-25 2006-11-30 Navinta Llc Novel process for preparation of isotonic aqueous injection of ropivacaine
EP2209450A4 (en) * 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
CA2871820C (en) * 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
CN105612155A (zh) * 2012-05-10 2016-05-25 塞利克斯比奥私人有限公司 治疗局部疼痛的组合物和方法
ES2699257T3 (es) 2013-02-28 2019-02-08 Dermira Inc Sales de glicopirrolato
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151110B1 (en) * 1983-08-01 1989-03-01 Astra Läkemedel Aktiebolag L-n-n-propylpipecolic acid-2,6-xylidide and method for preparing the same
SE9302218D0 (sv) * 1993-06-28 1993-06-28 Ab Astra New use

Also Published As

Publication number Publication date
DE69430427D1 (de) 2002-05-23
CZ283300B6 (cs) 1998-02-18
AU7086694A (en) 1995-01-17
PL312198A1 (en) 1996-04-01
RU2152215C1 (ru) 2000-07-10
CA2165446C (en) 2005-07-05
LV12918B (en) 2003-03-20
NO955313D0 (no) 1995-12-27
PL175518B1 (pl) 1999-01-29
DK0706395T3 (da) 2002-07-22
ES2099048T3 (es) 2002-11-16
FI956269A (fi) 1995-12-27
CN1074918C (zh) 2001-11-21
NO955313L (no) 1995-12-27
SK164695A3 (en) 1996-07-03
BR9406865A (pt) 1996-03-26
LT3449B (en) 1995-10-25
EP0706395A1 (en) 1996-04-17
IL110006A (en) 1999-01-26
SE9302218D0 (sv) 1993-06-28
FI956269A0 (fi) 1995-12-27
EP0706395B1 (en) 2002-04-17
DE706395T1 (de) 1997-09-04
HUT75115A (en) 1997-04-28
GR970300013T1 (en) 1997-05-31
US5834489A (en) 1998-11-10
LTIP1958A (en) 1995-01-31
JPH09500620A (ja) 1997-01-21
CA2165446A1 (en) 1995-01-05
AU692161B2 (en) 1998-06-04
WO1995000148A1 (en) 1995-01-05
NZ268110A (en) 1999-06-29
PH31258A (en) 1998-06-18
IL110006A0 (en) 1994-11-11
JP3725541B2 (ja) 2005-12-14
US5670524A (en) 1997-09-23
HU218949B (hu) 2001-01-29
MY119360A (en) 2005-05-31
HU9503692D0 (en) 1996-02-28
CZ336495A3 (en) 1996-06-12
SK280111B6 (sk) 1999-08-06
ATE216237T1 (de) 2002-05-15
HK1010344A1 (en) 1999-06-17
SA94150010B1 (ar) 2006-04-04
EE03205B1 (et) 1999-08-16
PT706395E (pt) 2002-09-30
DE69430427T2 (de) 2002-11-14
IS4174A (is) 1994-12-29
CN1126435A (zh) 1996-07-10
TW285640B (et) 1996-09-11
ES2099048T1 (es) 1997-05-16

Similar Documents

Publication Publication Date Title
EG22373A (en) New pharmaceutical formulation
IL113631A0 (en) New antagonist compounds
HK1010344A1 (en) Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
ZA965749B (en) Use of allylamines.